Vascular endothelial growth factor (VEGF) mediates increased vascular permeability and endothelial mitogenesis, and may orchestrate normal glomerular permselectivity and proteinuria. Distinct isoforms result from differential gene splicing. VEGF binds to two cell surface tyrosine-kinase receptors, KDR (kinase domain region) and Flt-1 (fms-like tyrosine kinase-1). The latter also exists in a soluble form (sFlt), which is inhibitory. We have studied patterns of VEGF-isoform and VEGF-receptor expression in isolated single normal human glomeruli. mRNA from 190 glomeruli (from 20 individuals) was harvested on to magnetic beads, and nested reverse transcription–PCR was performed using primers for the VEGF isoforms and VEGF receptors. Simultaneous nested reverse transcription–PCR for CD45 was conducted in order to exclude leucocyte contamination. Unexpected products were isolated, cloned and sequenced. Multiple patterns of glomerular VEGF mRNA isoform expression were identified. Most frequently (58%), all three common forms were expressed. VEGF189 (i.e. 189-amino-acid form of VEGF) was expressed in 63%, VEGF165 in 85% and VEGF121 in 84% of glomeruli. Two unexpected PCR products were also identified: 18% of glomeruli expressed VEGF145, and 27% of glomeruli expressed a new truncated VEGF splice variant, VEGF148, lacking exon 6, the terminal part of exon 7 and exon 8. Multiple patterns of VEGF-receptor expression were also identified, the most common being expression of all three isoforms (28%). Overall, KDR was seen in 59% of glomeruli, Flt-1 in 45% and sFlt in 57%. Thus the expression of VEGF within normal glomeruli is complex and variable, with inter- and intra-individual variation. Furthermore, sFlt appears to be the co-dominant form of VEGF receptor expressed within glomeruli, suggesting that, in healthy individuals, a degree of VEGF autoregulation is the norm. The physiological importance of VEGF148 remains to be confirmed.
Skip Nav Destination
Article navigation
Research Article|
July 21 1999
Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant
Catheryne WHITTLE;
Catheryne WHITTLE
*Academic Renal Unit, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, U.K.
Search for other works by this author on:
Kathleen GILLESPIE;
Kathleen GILLESPIE
*Academic Renal Unit, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, U.K.
Search for other works by this author on:
Rebecca HARRISON;
Rebecca HARRISON
†Department of Pathology, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, U.K.
Search for other works by this author on:
Peter W. MATHIESON;
Peter W. MATHIESON
*Academic Renal Unit, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, U.K.
Search for other works by this author on:
Steve J. HARPER
*Academic Renal Unit, University of Bristol, Southmead Hospital, Westbury-on-Trym, Bristol BS10 5NB, U.K.
Correspondence: Dr S J Harper.
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
January 05 1999
Revision Received:
April 13 1999
Accepted:
May 25 1999
Online ISSN: 1470-8736
Print ISSN: 0143-5221
The Biochemical Society and the Medical Research Society © 1999
1999
Clin Sci (Lond) (1999) 97 (3): 303–312.
Article history
Received:
January 05 1999
Revision Received:
April 13 1999
Accepted:
May 25 1999
Citation
Catheryne WHITTLE, Kathleen GILLESPIE, Rebecca HARRISON, Peter W. MATHIESON, Steve J. HARPER; Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant. Clin Sci (Lond) 1 September 1999; 97 (3): 303–312. doi: https://doi.org/10.1042/cs0970303
Download citation file:
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionGet Access To This Article
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |